SE8002192L - Forfarande for framstellning av immunoglobulin for intravenos administration - Google Patents
Forfarande for framstellning av immunoglobulin for intravenos administrationInfo
- Publication number
- SE8002192L SE8002192L SE8002192A SE8002192A SE8002192L SE 8002192 L SE8002192 L SE 8002192L SE 8002192 A SE8002192 A SE 8002192A SE 8002192 A SE8002192 A SE 8002192A SE 8002192 L SE8002192 L SE 8002192L
- Authority
- SE
- Sweden
- Prior art keywords
- immunoglobulin
- purified
- administration
- intramuscular injections
- intravenos
- Prior art date
Links
- 108060003951 Immunoglobulin Proteins 0.000 title abstract 6
- 102000018358 immunoglobulin Human genes 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 4
- 239000007927 intramuscular injection Substances 0.000 abstract 2
- 238000010255 intramuscular injection Methods 0.000 abstract 2
- 238000001990 intravenous administration Methods 0.000 abstract 2
- 206010002198 Anaphylactic reaction Diseases 0.000 abstract 1
- 102000006395 Globulins Human genes 0.000 abstract 1
- 108010044091 Globulins Proteins 0.000 abstract 1
- 239000003463 adsorbent Substances 0.000 abstract 1
- 238000001042 affinity chromatography Methods 0.000 abstract 1
- 230000036783 anaphylactic response Effects 0.000 abstract 1
- 208000003455 anaphylaxis Diseases 0.000 abstract 1
- 238000010420 art technique Methods 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
- Y10S530/831—Cohn fractions
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3347779A JPS55124719A (en) | 1979-03-22 | 1979-03-22 | Preparation of immune globulin administrable by intravenous injection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE8002192L true SE8002192L (sv) | 1980-09-23 |
Family
ID=12387617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8002192A SE8002192L (sv) | 1979-03-22 | 1980-03-21 | Forfarande for framstellning av immunoglobulin for intravenos administration |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4256631A (show.php) |
| JP (1) | JPS55124719A (show.php) |
| DE (1) | DE3010801C2 (show.php) |
| FR (1) | FR2451745A1 (show.php) |
| GB (1) | GB2044775B (show.php) |
| SE (1) | SE8002192L (show.php) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2846412A1 (de) * | 1978-10-25 | 1980-05-08 | Behringwerke Ag | Mittel zur behandlung allergischer reaktionen |
| AU558931B2 (en) * | 1981-02-26 | 1987-02-12 | Unilever Plc | A process and apparatus for the recovery of immunoglobulins |
| US4465670A (en) * | 1982-07-23 | 1984-08-14 | Dainippon Pharmaceutical Co., Ltd. | Method for the treatment of systemic lupus erythematosus and primary glomerulonephritis and agent therefor |
| US4639513A (en) * | 1984-02-02 | 1987-01-27 | Cuno Inc. | Intravenously injectable immunoglobulin G (IGG) and method for producing same |
| WO1986005397A1 (en) * | 1985-03-13 | 1986-09-25 | Nordisk Gentofte A/S | Immunosorbent for removal of rheumatoid factors from whole blood or blood plasma |
| JPH0662436B2 (ja) * | 1986-05-19 | 1994-08-17 | 株式会社ミドリ十字 | 静注用免疫グロブリン製剤の製造方法 |
| CA1308023C (en) * | 1988-07-29 | 1992-09-29 | William Austin James Mcauley | Immunoglobulin extraction utilizing properties of colloidal solutions |
| SE500110C2 (sv) * | 1989-06-27 | 1994-04-18 | Kabi Pharmacia Ab | Sätt att rena ett protein från därtill bundna flervärda metalljoner |
| US5250663A (en) * | 1990-04-19 | 1993-10-05 | Miles Inc. | Preparing essentially monomeric normal human serum albumin |
| US5219578A (en) * | 1991-02-25 | 1993-06-15 | Innovet, Inc. | Composition and method for immunostimulation in mammals |
| US20040101909A1 (en) * | 2002-08-20 | 2004-05-27 | Hema-Quebec, 2535 Boul. Laurier, Ste-Foy, Quebec, Canada G1V 4M3 | Purification of polyreactive autoantibodies and uses thereof |
| US8372287B2 (en) * | 2008-09-02 | 2013-02-12 | Als Group Usa, Corp | Impregnated expanded polytetrafluoroethylene (ePTFE) tubing as a stationary phase |
| US9107906B1 (en) | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
| US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
| GB201717446D0 (en) * | 2017-10-24 | 2017-12-06 | Evox Therapeutics Ltd | Affinity purification of engineering extracellular vesicles |
| JP2023526738A (ja) * | 2020-04-10 | 2023-06-23 | プラズマ テクノロジーズ エルエルシー | タンパク質の単純化した高効率単離のための組成物および方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2770616A (en) * | 1951-01-29 | 1956-11-13 | Protein Foundation Inc | Fractionation of proteinaceous materials in blood plasma and liver tissue |
| GB1247886A (en) | 1967-10-10 | 1971-09-29 | Sanofi Sa | Therapeutic immunoglobulins and process for their production |
| US3641235A (en) * | 1968-11-01 | 1972-02-08 | Miles Lab | Immunological reagent and process for making same |
| DE2234069A1 (de) | 1971-07-16 | 1973-02-08 | South African Inventions | Verfahren zur herstellung eines gereinigten gamma-globulins |
| FR2279419A1 (fr) * | 1974-07-25 | 1976-02-20 | Merieux Inst | Procede de preparation d'immunoglobulines purifiees, immunoglobulines purifiees obtenues et un medicament comprenant ces immunoglobulines purifiees |
| GB1541435A (en) * | 1975-02-04 | 1979-02-28 | Searle & Co | Immunological materials |
| US4075193A (en) * | 1976-11-26 | 1978-02-21 | Parke, Davis & Company | Process for producing intravenous immune globulin |
-
1979
- 1979-03-22 JP JP3347779A patent/JPS55124719A/ja active Granted
-
1980
- 1980-03-18 GB GB8009141A patent/GB2044775B/en not_active Expired
- 1980-03-18 US US06/131,539 patent/US4256631A/en not_active Expired - Lifetime
- 1980-03-20 DE DE3010801A patent/DE3010801C2/de not_active Expired
- 1980-03-21 SE SE8002192A patent/SE8002192L/xx not_active Application Discontinuation
- 1980-03-21 FR FR8006417A patent/FR2451745A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62885B2 (show.php) | 1987-01-10 |
| FR2451745B1 (show.php) | 1984-01-27 |
| GB2044775A (en) | 1980-10-22 |
| DE3010801C2 (de) | 1983-06-09 |
| GB2044775B (en) | 1982-12-01 |
| JPS55124719A (en) | 1980-09-26 |
| DE3010801A1 (de) | 1980-10-02 |
| FR2451745A1 (fr) | 1980-10-17 |
| US4256631A (en) | 1981-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8002192L (sv) | Forfarande for framstellning av immunoglobulin for intravenos administration | |
| DE58905514D1 (de) | Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen immunoglobulin-Präparates mit hohemIgM-Gehalt. | |
| EP0659767B1 (de) | Verfahren zur Herstellung eines Konzentrates von Anti-D-Immunoglobulin G und pharmazeutische Zusammensetzung, die dieses enthält | |
| ATE16567T1 (de) | Intravenoes injektierbares globulin aus immunserum und verfahren zu seiner herstellung. | |
| DE59008404D1 (de) | Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oder IgA-haltige Immunglobulinpräparate. | |
| DE3485649D1 (de) | Verfahren zur herstellung von antikoerperzusammensetzungen von therapeutischen mitteln mit verlaengerter serumhalbwertzeit. | |
| DE59208982D1 (de) | Verfahren zur Reinigung von IgG-monoklonalen Antikörpern | |
| SE7907045L (sv) | Forfarande for framstellning av ett intravenost administrerbart antikroppshaltigt immunglobulinpreparat och enligt forfarandet framstellda preparat | |
| DE2527064A1 (de) | Intravenoeses nativ-human-immunglobulin mit natuerlicher halbwertszeit | |
| NO912418L (no) | Fremgangsmaate for behandling av blaerecancerceller | |
| ATE9905T1 (de) | Herstellung von immunoglobulin mit hohem monomer- anteil. | |
| CA1153695A (en) | S-sulfonated immunoglobulin composition having a high monomer content and a process for production thereof | |
| JPH09124507A5 (show.php) | ||
| Hitzig et al. | Conventional immunoglobulin therapy | |
| AT381026B (de) | Verfahren zur herstellung einer nebenwirkungsfreien igg-immunglobulinloesung fuer die intravenoese applikation | |
| Miller et al. | Production of acute glomerulonephritis in mice with soluble antigen-antibody complexes prepared from homologous antibody. | |
| McCluskey | Evidence for immunologic mechanisms in several forms of human glomerular diseases | |
| ATE401912T1 (de) | Methoden der zubereitung von immunglobulin und dessen verwendungen | |
| Ochs | Intravenous immunoglobulin therapy of patients with primary immunodeficiency syndromes: efficacy and safety of a new modified immune globulin preparation | |
| EP0406216A2 (de) | Protein-S-hältige pharmazeutische Präparation | |
| DE3018901C2 (de) | Verfahren zur Herstellung von Immunoglobulinderivaten | |
| Sato | Studies on the fractionation of Haemophilus pertussis antitoxin | |
| Skvaril et al. | Anticomplementary properties of plasmin-treated human G immunoglobulin and its components | |
| Hartman | Bioavailability study of diphtheria immunoglobulin (human) | |
| Kishida et al. | An improved method for the production of antisera to G1m allotypes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8002192-6 Format of ref document f/p: F |